Ceci Connolly says generics market must be competitive to curb drug costs (CQ)

A lack of competition plays a central role in soaring drug costs, even among generic treatments. ACHP President and CEO Ceci Connolly explains that a lack of competition has led to arbitrary price increases and emphasizes that the generics market must be competitive in order to curb rising costs.